NM_000324.3:c.1147C>A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_000324.3(RHAG):c.1147C>A(p.Leu383Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000722 in 1,610,196 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000324.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHAG | ENST00000371175.10 | c.1147C>A | p.Leu383Ile | missense_variant | Exon 9 of 10 | 1 | NM_000324.3 | ENSP00000360217.4 | ||
RHAG | ENST00000646272.1 | c.1147C>A | p.Leu383Ile | missense_variant | Exon 9 of 10 | ENSP00000494337.1 | ||||
RHAG | ENST00000646939.1 | c.1025C>A | p.Ser342Tyr | missense_variant | Exon 8 of 9 | ENSP00000494709.1 | ||||
RHAG | ENST00000646963.1 | c.1138+237C>A | intron_variant | Intron 8 of 8 | ENSP00000495337.1 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000275 AC: 69AN: 250974Hom.: 0 AF XY: 0.000346 AC XY: 47AN XY: 135644
GnomAD4 exome AF: 0.000750 AC: 1093AN: 1457926Hom.: 3 Cov.: 29 AF XY: 0.000718 AC XY: 521AN XY: 725552
GnomAD4 genome AF: 0.000453 AC: 69AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74454
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
The RHAG p.Leu383Ile variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs141051794) and in control databases in 85 of 282380 chromosomes at a frequency of 0.000301 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 77 of 128868 chromosomes (freq: 0.000598), European (Finnish) in 5 of 25096 chromosomes (freq: 0.000199), Other in 1 of 7204 chromosomes (freq: 0.000139) and African in 2 of 24960 chromosomes (freq: 0.00008), but was not observed in the Latino, Ashkenazi Jewish, East Asian, or South Asian populations. The p.Leu383 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
not specified Uncertain:1
The c.1147C>A (p.L383I) alteration is located in exon 9 (coding exon 9) of the RHAG gene. This alteration results from a C to A substitution at nucleotide position 1147, causing the leucine (L) at amino acid position 383 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at